Projected Income Statement: Molecure S.A.

Forecast Balance Sheet: Molecure S.A.

Forecast Balance Sheet - Molecure S.A.
Fiscal Period: December 2022 2023 2024 2025 2026 2027
Net Debt 1 - -56.8 -11 -11.1 3.9 -1
Change - - 80.63% -0.91% 112.62% -125.64%
Announcement Date 3/29/23 5/17/24 3/27/25 3/10/26 - -
1PLN in Million
Estimates

Cash Flow Forecast: Molecure S.A.

Fiscal Period: December 2023 2024 2026 2027
CAPEX 1 44.51 -23.77 25.6 -
Change - -153.42% - -100%
Free Cash Flow (FCF) 1 - - -33 -1
Change - - - 96.97%
Announcement Date 5/17/24 3/27/25 - -
1PLN in Million
Estimates

Forecast Financial Ratios: Molecure S.A.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

         
EBITDA Margin (%) - - - - -1,525.16% -970.76% -207.81% -412.84% -29.69%
EBIT Margin (%) - - - - -1,664.3% -1,100.95% -253.99% -450.92% -43.42%
EBT Margin (%) - - - - -1,378.52% -1,066.38% - -192.66% -16.81%
Net margin (%) - - - - -1,378.52% -1,066.38% -240.64% -453.67% -46.78%
FCF margin (%) - - - - - - - -454.13% -5.6%
FCF / Net Income (%) - - - - - - - 100.1% 11.98%

Profitability

         
ROA -3.51% 38.52% -5.57% -7.33% -19.71% -17.87% - - -
ROE -5.17% 57.77% -9.46% -11.41% -31.33% -30.62% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - - - - - - -0.13x -
Debt / Free cash flow - - - - - - - -0.12x -

Capital Intensity

         
CAPEX / Current Assets (%) - - - - 3,351.13% - - 352.29% -
CAPEX / EBITDA (%) - - - - -219.72% - - -85.33% -
CAPEX / FCF (%) - - - - - - - -77.58% -

Items per share

         
Cash flow per share 1 - - - - - - - - -
Change - - - - - - - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - 9.339 5.118 - 5 4
Change - - - - - -45.19% - - -20%
EPS 1 - - - -1.09 -1.09 -1.55 - -0.6 -0.1
Change - - - - 0% -42.2% - - 83.33%
Nbr of stocks (in thousands) - - - 14,030 16,836 16,836 - 20,603 20,603
Announcement Date - - - 3/29/23 5/17/24 3/27/25 - - -
1PLN
Estimates
2025 2026 *
P/E - -8.67x
PBR - 1.04x
EV / Sales 19.2x 15.3x
Yield - -

EPS & Dividend

EPS & Dividend - Molecure S.A.


Y-o-Y evolution of P/E

Valuation ratios - P/E - Molecure S.A.
 
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Molecure S.A.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.200PLN
Average target price
12.80PLN
Spread / Average Target
+146.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Molecure S.A.
  1. Stock Market
  2. Stocks
  3. MOC Stock
  4. Financials Molecure S.A.
BLACK FRIDAY -Get 40% off all subscriptions
BLACK FRIDAY40% off all subscriptions
Get the offer